Chaffer et al., 1997 - Google Patents
Vaccination of turkey poults against pathogenic Escherichia coliChaffer et al., 1997
View PDF- Document ID
- 6711327054877316121
- Author
- Chaffer M
- Schwartsburd B
- Heller E
- Publication year
- Publication venue
- Avian Pathology
External Links
Snippet
A vaccine made of bacterial membranes which form vesicles has been developed in our laboratory and found to be effective in protecting chickens against challenge with pathogenic E. coli. In the present study we monitored maternal anti‐5. coli antibody in turkey …
- 241000588724 Escherichia coli 0 title abstract description 6
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gast et al. | Salmonella infections | |
US6399074B1 (en) | Live attenuated salmonella vaccines to control avian pathogens | |
Tizard | Vaccines for Veterinarians E-Book | |
Roland et al. | Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens | |
Hassan et al. | Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-type Salmonella strains | |
Rabie et al. | Bacterial vaccines in poultry | |
CA2134835C (en) | Live in ovo vaccine | |
DE69322092T2 (en) | NEW BACTERIAL VACCINES USING VACCINE STRAINS FROM PATHOGENIC BACTERIA | |
WO2012092226A1 (en) | Veterinary vaccine composition against infections caused by salmonella | |
Vishwanath et al. | A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever | |
JP2009531029A (en) | Attenuated Salmonella live vaccine | |
Deb et al. | Laboratory trials with inactivated vaccines against Escherichia coli (O2: K1) infection in fowls | |
Chaffer et al. | Vaccination of turkey poults against pathogenic Escherichia coli | |
JP5745731B2 (en) | Salmonella vaccine | |
ES2824402T3 (en) | Attenuated vaccines against Pasteurella multocida and procedures for their manufacture and use | |
Mitobe et al. | An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype | |
Zhang et al. | Protection and immune responses induced by attenuatedSalmonella typhimuriumUK-1 strains | |
Tabatabaei et al. | Vaccine efficacy in cattle against hemorrhagic septicemia with live attenuated aroA mutant of Pasteurella multocida B: 2 strain | |
HU203673B (en) | Process for producing vaccine for prophilacting escherichia coli toxaemia of domestical birds | |
PL206589B1 (en) | Novel bacterial poultry disease | |
DE60032293T2 (en) | LIVING ATTENUATED BACTERIA FOR USE AS A VACCINATE | |
Yousif et al. | Oral administration of hyperimmune IgY: an immunoecological approach to curbing acute infectious bursal disease virus infection | |
TW200418874A (en) | Passive vaccine for the prevention of campylobacter colonization, and its preparation method | |
EP2934580B1 (en) | A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation | |
Sen et al. | Immunogenicity and duration of immunity of the polyvalent vaccine against chicken salmonellosis |